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Abstract
Background: Despite progress reducing maternal mortality, HIV-related maternal deaths remain high, accounting, for
example, for up to 24 percent of all pregnancy-related deaths in sub-Saharan Africa. Antiretroviral therapy (ART) is effective
in improving outcomes among HIV-infected pregnant and postpartum women, yet rates of initiation, adherence, and
retention remain low. This systematic literature review synthesized evidence about individual and contextual factors
affecting ART use among HIV-infected pregnant and postpartum women.
Methods: Searches were conducted for studies addressing the population (HIV-infected pregnant and postpartum women),
intervention (ART), and outcomes of interest (initiation, adherence, and retention). Quantitative and qualitative studies
published in English since January 2008 were included. Individual and contextual enablers and barriers to ART use were
extracted and organized thematically within a framework of individual, interpersonal, community, and structural categories.
Results: Thirty-four studies were included in the review. Individual-level factors included both those within and outside a
woman’s awareness and control (e.g., commitment to child’s health or age). Individual-level barriers included poor
understanding of HIV, ART, and prevention of mother-to-child transmission, and difficulty managing practical demands of
ART. At an interpersonal level, disclosure to a spouse and spousal involvement in treatment were associated with improved
initiation, adherence, and retention. Fear of negative consequences was a barrier to disclosure. At a community level, stigma
was a major barrier. Key structural barriers and enablers were related to health system use and engagement, including
access to services and health worker attitudes.
Conclusions: To be successful, programs seeking to expand access to and continued use of ART by integrating maternal
health and HIV services must identify and address the relevant barriers and enablers in their own context that are described
in this review. Further research on this population, including those who drop out of or never access health services, is
needed to inform effective implementation.
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Background
HIV is responsible for a large proportion of indirect maternal
deaths in countries with high HIV prevalence [1–3]. New [1]
analyses reveal that there is wide range in the estimated impact of
HIV on pregnancy-related and maternal mortality from 24
percent of pregnancy-related deaths [4] to 6.4 percent of maternal
deaths [5] in sub-Saharan Africa. Globally, estimates range from
roughly 21 percent to 0.4 percent of maternal deaths [6] that are
related to HIV. However, the impact of HIV on pregnancy and
maternal mortality is substantial for countries with high HIV
prevalence [7]. Hospital-based studies in Africa have shown
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relative risks of pregnancy-related death among HIV-infected
women ranging from two to eight-times greater than in non-
infected women [8]. There is also evidence of increased risk of
direct obstetric complications, such as sepsis, among HIV-infected
pregnant women [8,9].
In countries where HIV is highly prevalent, HIV infection is a
leading cause of pregnancy-related deaths and has even reversed
gains in reducing maternal mortality [2]. Many of these countries
struggle to maintain adequate health system capacity to meet the
associated service needs. Antiretroviral therapy (ART) is effective
in reducing maternal mortality among HIV-infected women [10],
but ART initiation, adherence, and retention in care remain
problematically low in some regions, even when ART is available
[11]. There is an urgent need to understand the factors affecting
the uptake of this critical intervention in order to improve
programming and extend the reach of services and supportive
interventions to this population.
This review is one of three systematic reviews that together
consider evidence around efforts to reduce mortality among HIV-
infected pregnant and postpartum women. One review assesses the
evidence on the effectiveness of interventions to decrease death
and morbidity among HIV-infected women during pregnancy and
up to one year postpartum [12]; another review examines the
health system barriers and enablers to ART initiation, adherence,
and retention and evidence on health system interventions that
may facilitate access to maternal ART [13]. This current review
synthesizes evidence on the individual and contextual barriers to
and enablers of ART initiation, adherence, and retention among
the same population. This systematic review was guided by the
following question:
What are the individual and contextual factors affecting the
initiation, adherence, and retention to ART among HIV-
infected pregnant women during and following pregnancy?
Factors of interest include those individual, interpersonal,
community, and structural forces which influence an HIV-infected
woman’s ability to initiate, adhere to, or be retained in ART care.
Some health system factors identified in the other above-
mentioned review are closely related to contextual factors
identified in this review. We have included information on health
systems factors if they capture the woman’s perspectives on or
experiences of health system issues.
Methodology
Review Design
We undertook a systematic review of both qualitative and
quantitative evidence of individual and contextual factors that
inhibit or enable access to and use of ART for HIV-infected
pregnant and postpartum women. Study findings were analyzed
thematically and we used a conceptual framework for data
extraction and synthesis that was informed by the World Health
Organization (WHO) health systems framework [14] and
Supporting the Use of Research Evidence (SURE) framework
[15].
Study Eligibility
Inclusion Criteria. To maximize the breadth of the study
findings, we included any study that reported empirical qualitative
or quantitative findings relevant to the review question. Studies
from low- and middle-income countries (LMICs), as well as high-
income countries, were included, as were studies conducted in
community or health system settings. Due to time and resource
constraints, we only included studies written in English. To
maximize the relevance of the study findings to current maternal
ART policy and practice, we only included studies published
between January 1, 2008 and March 26, 2013.
Because this review was conducted in parallel with a separate
but linked systematic review of health systems factors affecting
ART initiation, adherence, and retention for pregnant and
postpartum women [13], we only included studies that described
health systems-related factors if these were described from the
woman’s perspective or experience. For example, long waiting
times at health facilities are a contextual barrier from women’s
perspectives when they do not attend services because they do not
believe they have enough time to wait. Long waiting times may
also reflect broader supply-side issues within the health system,
such as inefficient models of care or system-level resource
constraints.
Exclusion Criteria. Studies were excluded if they focused on
HIV-infected pregnant or postpartum women on ART and/or in
PMTCT programs but did not identify individual or contextual
barriers or enablers of ART initiation, adherence, or retention.
We excluded studies that reported on relevant health systems
barriers and enablers if there was no discussion of these factors
from the perspective of pregnant women. We also excluded studies
of broader cohorts of people with HIV (e.g., all adults on ART) if
barriers and enablers specific to pregnant or postpartum women
could not be distinguished in the findings.
Search Strategy and Selection Process
Search strategy. Both peer-reviewed journal articles and
gray literature were searched to identify eligible studies. Peer-
reviewed journal articles were searched systematically in the
PubMed and Social Sciences Citation Index (SSCI) databases
using variations of three key terms:
N Population of interest (i.e., pregnant women and postpartum
women infected with HIV);
N Intervention of interest (i.e., ART);
N Outcomes of interest (i.e., initiation, adherence, retention).
A full search strategy for one of the database searches can be
found in the Supporting Information. Gray literature was also
searched on relevant conference abstract databases, multilateral
and bilateral agency websites, and websites of non-governmental
organizations (NGOs) conducting research or implementing
programs of relevance. Articles and abstracts were excluded if
they did not address the population, interventions or outcomes of
interest.
Study selection. Studies were selected for review in two
stages. First, three review authors independently assessed the first
100 abstracts retrieved from PubMed. Each reviewer’s list of
selected articles and accompanying rationale was compared with
the list from the other reviewers; discrepancies were discussed and
resolved. Inclusion and exclusion criteria were refined and clarified
during this process. In the second step, one review author (SK)
reviewed the remaining abstracts and included or excluded studies.
Quality Assessment and Data Extraction
Characterizing the evidence base. In order to assess the
strength of the underlying evidence base for the review, we first
developed an overview of key characteristics of the included
studies by summarizing several variables, including study design,
sample size and strategy, geographic region, healthcare setting,
and risk of bias. We then ranked each included study as low,
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medium, or high with respect to overall risk of bias. Given the
diversity of study designs included and the difficulty of comparing
study quality assessments across widely varying study types, these
rankings were based on criteria appropriate to each study design
(e.g. different quality appraisal criteria were used for qualitative
and quantitative studies). These rankings were further justified via
short narratives. This provided an overview of the quality of the
existing evidence base, as represented by the included studies. No
studies were excluded on the basis of the quality assessment.
Rather the quality assessment process was used to identify
weaknesses in study methodologies and to guide the interpretation
and assessment of study findings.
Data extraction and management. Once the study selec-
tion process was concluded, one review author (SK) extracted data
from the studies using a standard template. Initial data extraction
captured both the study characteristics (e.g., setting, participants,
and type of ART program reviewed) as well as key findings related
to factors associated with initiation, adherence, and retention of
ART. A second author (IH) also reviewed the studies and
extracted data relating to key individual and contextual barriers
and enablers associated with initiation, adherence, and retention.
Extracted findings from both authors were compared and
discrepancies resolved.
Data Synthesis
The barriers and enablers identified were arranged thematically
within a framework of individual, interpersonal, community, and
structural categories [16]. These categories were further divided
into enabling factors and barriers to ART adherence, e.g.,
knowledge about HIV or ART or wanting to protect one’s child
(individual-level enablers); domestic violence or spousal depen-
dence (interpersonal-level barriers); stigma (community-level
barrier); or health worker attitude or support group participation
(structural-level enablers). This framework was reviewed by all
review authors for accuracy and comprehensiveness.
The intention of the analysis process was to produce a detailed
list of factors that have been reported as affecting the three ART
outcomes of interest for pregnant and postpartum women, and to
offer, when possible, brief explanations for how these factors might
operate and in which contexts they were most salient. Given the
diversity of disciplinary approaches, sociocultural contexts, study
questions, and study designs in this review’s included studies and
the broad scope of the review question, it was not possible to
develop the analysis of these factors further than a straightforward
thematic analysis. The intention, therefore, is not to provide a rich
explanatory model for how each of these factors might work, or to
develop a global theory of barriers and enablers to maternal ART.
Rather, the analysis is intended to provide policymakers and
practitioners with a roadmap for how to think about, and where to
look for, the factors that might shape pregnant and postpartum
women’s access to ART.
As a final step in the analysis process, we assessed our
confidence in each of the ‘‘key review findings’’ by describing
the strength and generalizability/transferability of the evidence
supporting that finding. For each review finding, therefore, we
looked back at the studies that contributed to that finding and
considered: 1) how strong the underlying study design was, 2) what
the risk of bias was, 3) what level of detail and/or context was
provided to enable interpretation, and 4) how frequently the
review finding was found across the individual studies. This
approach is modeled on the CERQual approach to assessing the
confidence in findings of qualitative systematic reviews [17]. We
then ranked the strength of the evidence underlying each finding
as high, moderate or low.
We were also interested in the generalizability or transferability–
depending on whether we were considering quantitative or
qualitative evidence–of the evidence with respect to public sector
health services in low and middle-income countries with high HIV
prevalence (where most of the global burden lies and where
women and programs need the most support). The concept of
‘transferability’ is used in assessing qualitative research findings as
a more appropriate alternative to the concept of ‘generalizability’
[18]. Transferability expresses the degree to which the study
authors have provided contextual information and other forms of
‘thick description’ that allow the reader to determine to which
other contexts particular findings might be transferable. For each
key review finding, we therefore asked two additional questions: 5)
how many of the studies supporting this finding were conducted
within existing services settings, and 6) how many came from
LMICs with high HIV prevalence. Here too, we ranked
generalizability or transferability as high, moderate or low.
Findings on the strength and generalizability or transferability of
review findings to high prevalence settings have been provided
below along with a brief narrative justification for each. No studies
were excluded based on the quality appraisals of the studies, but
most studies used to illustrate core findings in the text were
supported by strong evidence.
Results
Overview of Studies Included and ART Regimens
The results of the peer-reviewed journal article and gray
literature search are summarized in the flow diagram in Figure 1.
The peer-reviewed journal article search yielded 672 articles, of
which 31 were included in the core review. A total of 1,487 grey
literature documents were assessed, of which three were selected
for inclusion in the review.
Thirty-four studies met the inclusion criteria for this review [19–
52]. Table 1 provides a brief overview of the key characteristics of
the included studies. A more detailed table is available in the
Supporting Information that provides information on each of the
studies reviewed, including each study’s location, design, popula-
tion size, type of ART program, and key findings related to
initiation, adherence and retention during pregnancy and
postpartum.
Twenty-seven of the studies were carried out in sub-Saharan
Africa, one in Asia, two in Latin America, and four in Europe and
the US. Sixteen studies used quantitative methods, twelve used
qualitative methods and six employed both qualitative and
quantitative methods. Most study participants were HIV-infected
pregnant or postpartum women. Eight studies included data from
interviews or focus group discussions with health care workers,
community members, partners, and/or family members of HIV-
infected pregnant and postpartum women.
Four studies described and evaluated interventions. These
include: a study from Zambia exploring the benefits of couple
counseling for initiation [32]; a study from South Africa describing
the impact of text messaging on promoting positive health choices
[52]; another study from South Africa describing the benefits of
rapid ART initiation among pregnant women [44]; and a study
from Malawi exploring the use of community health workers in
promoting ART adherence [34].
There were a number of different prevention of mother-to-child
transmission (PMTCT) and maternal ART regimens used in the
included studies. Seven studies involved women who had initiated
ART for therapeutic reasons before they enrolled in a PMTCT
program. Twenty-one studies included participants not on ART
who then enrolled in PMTCT programs, and examined factors
Social/Contextual Factors for ART in HIV+ Pregnant & Postpartum Women
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influencing ART initiation, adherence and/or retention during
pregnancy and, depending on regimen, for a brief period
thereafter. The regimens used in these studies included use of
single-dose nevirapine (sdNVP), Option A, and Option B regimens
(described in more detail in Table 2) [53–55].
Six studies involved women who were initiated on ART for
therapeutic reasons after being enrolled in a PMTCT program.
These women were eligible to initiate ART because of their
advanced clinical disease and/or high CD4 count. All of the
reviewed studies preceded the introduction of Option B+ (where
all pregnant HIV-infected women are initiated/supported on
lifelong ART regardless of WHO clinical stage and/or CD4
count). Thus, no reviewed studies examined ART initiation,
adherence, or retention within an Option B+ program.
The one-time nature of the sdNVP-based PMTCT regimen
means that it has only limited comparability to situations in which
a woman might begin long-term or life-long ART during
pregnancy. Papers reporting on sdNVP-based programs were
excluded from the review unless they addressed barriers and
enablers relevant to initiation, adherence or retention from the
woman’s point of view; seven such sdNVP-focused studies were
included.
Figure 1. Flow Diagram for Study Search and Inclusion.
doi:10.1371/journal.pone.0111421.g001
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Overview of Barriers and Enablers Identified
Individual and contextual factors influencing ART initiation,
adherence, and retention for pregnant and postpartum women
were identified through qualitative participant reports, study
author observations and interpretations, and quantitative mea-
sures of association reported in the studies. Data were extracted
from both the findings sections of study reports as well as ‘second-
order’ author interpretations of findings [56] in the discussion
sections of papers.
Key barriers and enablers to ART initiation, adherence, and
retention identified in the studies were categorized thematically
within individual, interpersonal, community, and structural levels
of influence. This approach to organising and understanding the
factors shaping health practices, processes and outcomes is
typically defined as the ‘socio-ecological’ approach [57–59]. While
the findings have been divided into these four different levels of
analysis, they are of course not all independent, and in fact many
factors identified at one level may interact with other factors within
and between levels (e.g., fear of stigma at the individual level and
norms around non-disclosure at the community level).
An overview of the key identified factors is presented in Table 3.
This table summarizes enablers and barriers separately, by the
relevant outcome of interest. A more comprehensive table is
available in the Supporting Information that provides the same
information in more detail, showing the hierarchy of main themes
and subcategories, and, for each finding, which studies contributed
to the finding. The assessment of our confidence in these findings
is provided in Table 4.
The findings extracted from the studies were identified with
respect to which outcomes they related to (initiation, adherence, or
retention), which region of the world they came from, the
socioeconomic status of study participants, and whether they were
from low or high prevalence settings. We used these characteristics
to develop ‘sub-groups’ of the various findings, searching for
example, for whether or not there were distinct variations in the
barriers and enablers identified by region, or by type of outcome.
In Table 3, and in the narrative findings below, we distinguish
which specific findings applied to each of the three outcomes. We
also make consistent reference in the narrative to the countries and
world region(s) that contributed to particular findings.
Making further generalizations about patterns of findings within
these sub-groups has been difficult, however, for several reasons.
One is that the body of studies that contributed the most to the
review findings are the studies that came from high-prevalence
settings in Eastern and Southern Africa. A second challenge has
been the fact that in most cases, findings are only supported by
one, two, or three studies, making comparisons along various axes
of region, prevalence, or outcome difficult. Finally, many of the
studies provide little detailed context on the study setting and
implementation process of the programs under review. Absent
such context, it is difficult to develop confident explanations about
how context (e.g. HIV prevalence or the SES of participants or the
wealth of a particular country) might affect the finding in more
precise ways.
Individual factors
Individual-level enablers and barriers to pregnant or postpar-
tum women’s ART initiation, adherence, and retention include
those within a woman’s awareness and control (e.g., commitment
to a child’s health), and those that may be outside of her awareness
or control (e.g., where she lives or her level of knowledge about
HIV, ART, or PMTCT).
Socio-demographic attributes. Age was associated with
ART initiation, adherence and retention in several of the included
studies, albeit in contrasting ways. Two studies, one from
Tanzania and one from the US, found that younger women were
less likely than older women to engage with the health system and/
or adhere to ART [25,35]. In contrast, a multi-country study of
long-term ART in Latin America found that non-adherence
increased by six percent with each one-year increase in age. The
study’s authors posited that these findings might relate to the
higher demands on older women living with HIV, particularly
those with children under 18 [37].
Education was also noted as an important factor. Two studies
from Kenya and one from the US found that women’s education
level was positively associated with ART adherence [20,21,36].
Ayuo et al. [20], in their Kenyan study of pregnant women
initiating ART, reported that each additional year in school
increased the likelihood of reporting perfect adherence by 10.6
percent. Similarly, a study in Rwanda found that women with
lower education levels were less likely to participate in an sdNVP
program. The study’s authors posited that higher education levels
contributed to better health literacy, which in turn promoted
sdNVP program initiation and adherence [26].
Finally, two studies in Kenya found that rural residency was a
barrier to ART initiation and adherence. In the first study, women
enrolled in HIV care at a rural clinic were more likely to be lost to
follow-up than women enrolled in similar care in a district hospital
[20]. In the second study, a qualitative narrative analysis, HIV-
infected pregnant women in rural settings were less likely to
disclose their HIV status than urban women. The authors argued
that these women, in striving to keep their status a secret, were
more likely to miss clinic appointments, resulting in poor ART
adherence [48].
Table 1. Summary of Key Characteristics of Included Studies.
Characteristics Number of studies
Regions
Sub-Saharan Africa 27
Asia 1
Latin America 2
Europe/North America 4
Middle East 0
Geographic Setting
Rural 6
Urban 12
Both 11
Unclear 5
HIV Prevalence Rates
Low (0–5%) 9
Moderate (5–15%) 11
High (15% or higher) 14
Study Designs
Quantitative methods 16
Qualitative methods 12
Mixed methods 6
Explicit Intervention Tested
Yes 4
No 30
doi:10.1371/journal.pone.0111421.t001
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Knowledge of HIV, ART, PMTCT and the Health
Services. In three studies in Uganda, South Africa, and
Tanzania, a lack of knowledge about health services and/or
ART was associated with poor ART adherence [41] or retention
[27,50]. Similarly, three other studies in Kenya, Ghana, and South
Africa found that sufficient knowledge of PMTCT facilitated ART
initiation, adherence and/or retention during and after pregnancy
[22,36,47]. For example, the Ghana study found that many study
participants had a high level of essential HIV knowledge (e.g.,
routes of transmission; the role of ARVs in prolonging life), but
that women with inadequate knowledge of PMTCT and ART
were significantly more likely to be lost to follow-up [22].
Fears and Aspirations Related to HIV, ART and
Motherhood. Several studies identified women’s fears as
barriers to ART initiation and/or adherence. For example, fear
of losing a job or fear of being HIV-infected contributed to
inaction and/or denial about one’s HIV status. Some studies
found that women feared HIV testing or the ARVs themselves,
including a South African sdNVP study [47] and studies on ART
in Tanzania and Malawi [23,50]. Two South African studies
found women’s unwillingness to commit to lifelong treatment as a
barrier to ART initiation [43,47]. Furthermore, two studies from
the US and Australia found that women feared ART would have a
negative impact on their children [39,40].
The review of literature also found that women’s desire to
protect her health and her children’s health could positively
influence ART initiation, adherence, and retention. In a Nigerian
study, an active desire to remain healthy and/or to protect one’s
child was an enabler of ART initiation and adherence [28]. A
desire to protect one’s children also motivated ART adherence
among women in a US study [40] and ART initiation among
women in two South African studies [43,47].
Women’s concerns about maintaining their status within their
families sometimes led them to keep their HIV infection a secret,
creating a barrier to initiation, adherence and retention. Some
women in a Kenyan study felt that disclosure of their HIV status
would undermine their roles as mothers and homemakers. This
non-disclosure made ART initiation and adherence particularly
challenging for the women during pregnancy, when elder women
in their families make decisions about their health care [48].
Another Kenyan study found that women were reluctant to attend
clinics for ART services because their visibility during long waiting
times could reveal their HIV status and, in turn, enhance their risk
of being stigmatized and perceived as incapable mothers [19].
Challenges to the Practical Demands of
Treatment. Individuals experienced a wide variety of barriers
to the day-to-day practical requirements of treatment adherence.
These included difficulty remembering to take medication,
misplacing medications, travel away from home, scheduling
conflicts with work, and lack of regular access to food or water.
Forgetting to take medication was reported in six studies, including
an sdNVP study in Rwanda [26], and pregnancy and postpartum
ART studies in Latin America, Nigeria, South Africa, and
Tanzania [28,35,37,41]. Research in Zimbabwe found that being
away from home and/or misplacing medicines impeded women’s
ART adherence [38], and similarly, a study in South Africa found
that being away from home created a barrier when treatment was
required [41].
Women also reported that scheduling challenges (e.g., due to
work commitments) affected both adherence and retention,
Table 2. Antiretroviral medication regimens in included studies.
Regimen Purpose: PMTCT Prophylaxis* Purpose: Treatment for the Mother Notes
Single-dose
nevirapine
(sdNVP)
One intrapartum dose taken at the
beginning of a woman’s labor
N/A Introduced in 2000, this regimen is no
longer recommended by WHO unless as
part of combination PMTCT (Option A)
Option A For pregnant women living
with HIV with CD4.350
For pregnant women with
CD4 cells ,350 or clinical
Stage 3–4 disease
(a) Antepartum: Antenatal zidovudine
(AZT) twice daily starting as early as
14 weeks gestation
Triple antiretroviral medications (ARVs)
often combined within a single pill
(a ‘‘fixed dose combination’’) that is
taken twice daily, starting as soon as
diagnosed and continued for life
(b) Intrapartum: at onsent of labor,
sdNVP and AZT every 3 hours and
lamivudine (3TC) every 12 hours until
delivery
(c) Postpartum: twice daily
AZT/3TC for 7 days
Option B Triple ARVs starting as early as
14 weeks gestation and continued
intrapartum and through
childbirth if not breastfeeding
or until 1 week after cessation of
breastfeeding
Triple ARVs starting as
soon as diagnosed,
continued for life
Under WHO’s 2010 PMTCT ARV guidance,
countries have the option to choose
between two prophylaxis regimens for
pregnant women living with HIV: Option
A and Option B.
Option B+ Triple ARVs starting as soon as
diagnosed, continued for life
Triple ARVs starting as
soon as diagnosed,
continued for life
Option B+ was conceived and
implemented in Malawi in 2011. In April
2012, WHO released a programmatic
update in which it urged countries to
consider Option B and B+
*PMTCT prophylaxis refers to the use of ARV drugs solely for the purpose of reducing the risk of vertical transmission when a woman is not on standard ART for
therapeutic reasons.
doi:10.1371/journal.pone.0111421.t002
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Table 4. Strength of Evidence and Generalizability/Transferability of Key Review Findings to High Prevalence Contexts.
Level of
Influence Key Review Finding Strength of Evidence Summary Generalizability/Transferability Summary
Individual 1a) Socio-demographic factors
(i.e., age,
educational level,
residency) can influence
ART initiation, adherence,
and retention.
High Eight papers reported a range of
socio-demographic factors. Age and educational
level were most widely reported as specific findings
in papers with strong quantitative designs,
specifically that older women, or those achieving
a higher level of education, were more likely to
adhere. Residency was reported in two
papers – one quantitative (women in central
hospitals were less likely to disengage than
women in smaller and more remote hospitals),
and one qualitative/descriptive, focusing on
challenges in rural communities around maternal roles.
Moderate This finding was reported across a range
of contexts, and is generalizable, although issues
around maternal role may be context-based.
1b) Level of knowledge
about health services,
ART, and/or PMTCT can
affect ART initiation,
adherence, and retention.
Moderate Six papers reported on the
association between knowledge (of health
services, or ART) and adherence. Mixed method
and quantitative designs reported higher levels
of knowledge correlating with adherence.
One qualitative study based on focus group
discussions and one paper derived from a
conference abstract confirmed the other
studies’ findings. Knowledge of the referral
process was only cited as an enabler in one
mixed method paper.
High This finding was reported across a range of
contexts, with no anomalies, and is likely to apply
broadly, although evidence for knowledge of the
referral process requires further exploration.
1c) Women’s fears and
perceptions of treatment,
and the desire to
maintain their roles
and status within
families, can affect
ART initiation, adherence,
and retention.
Moderate Eleven papers reported on these issues.
Qualitative and mixed method studies with strong
designs reported that a woman’s role in the family
may conflict with her needs as a patient. A desire
to protect children from HIV was reported in
qualitative studies and one quantitative study,
although the latter was only a second order
interpretation.
Moderate Evidence relating to these factors was
internally consistent within the review, although it
did include second order interpretations. The
particular forms these factors take are likely to be
context-based.
1d) Factors in a woman’s
daily life can affect ART
initiation, adherence, and
retention.
High Challenges managing the practical
demands of ART were reported in 12 quantitative
or mixed method papers, and included day-to-day
demands or (in one mixed method paper) lack
of access to water and/or food. Scheduling
problems, or being away from home, were
frequently reported barriers to adherence.
All findings were of first order interpretation.
Moderate Evidence relating to these factors was
internally consistent within the review, although the
particular forms these factors take are likely to be
context-based.
1e) Beliefs (e.g., religious
beliefs, feeling healthy,
and having a positive
outlook) can affect
ART initiation, adherence,
and retention.
Moderate Seven papers reported that
individual beliefs affected initiation, adherence,
and retention. The finding about feeling too
well to attend HIV services was only a second
order interpretation in one quantitative paper
and a report by one respondent in a qualitative
study. Feeling ‘happy’ was significant in one
quantitative study. The positive role of religion
was a strong finding in two papers, though one
(quantitative) was a second order interpretation.
Advice to use traditional medicines instead of ART
was only cited as a barrier in only one mixed
method study, but it was a core finding.
Moderate Evidence was reported across a range of
contexts, confirming the relevance of the broad
finding, but specific examples are likely to be
context-dependent.
1f) Behavioral factors
can be key barriers to
ART initiation, adherence,
and retention.
High Behavioral factors influencing ART
initiation, adherence, and retention were
reported in eight papers. Three quantitative
papers with strong designs reported use of
alcohol or illegal drugs as barriers to adherence.
Four quantitative studies, and one mixed method
study, reported evidence that forgetting, or
misplacing, medication was a barrier to adherence.
High This finding was reported across a wide range
of contexts; the two essential components can be
generalized.
Interpersonal 2a) Relationships with
partners can have a
substantial influence
on ART initiation,
adherence, and retention.
High This finding was reported across 14 studies,
with quantitative and qualitative designs. Five
of the papers also reported on issues around
gender dynamics and six of the papers reported
on the benefits of disclosure to a partner to
adherence. One quantitative paper reported
a significant and contrary finding that not
disclosing HIV status to a partner enabled
adherence, but this was not reported elsewhere.
High This broad finding was reported across a wide
range of contexts, arguing for a high validity. The one
finding that non-disclosure to a partner enabled
adherence highlights how the nature of interpersonal
influence may vary by context.
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specifically for registration or ART visits in Nigeria and Zimbabwe
and for support group meetings in South Africa [28,42,52]. Three
studies in Kenya, Tanzania, and South Africa identified lack of
food, water, or income as barriers to ART adherence; women
were less likely to adhere to their medications when food was
unavailable, because taking ART on an empty stomach often
caused negative side effects [19,35,41].
Two studies in Africa, on the other hand, found that ART
adherence among women was facilitated by the use of mobile
phones and/or enrolment in a postnatal care program. Women in
a South African study said they forgot to take ART medication
because their phones were turned off, which the authors
interpreted to mean that the women were using their phones for
personal organization [41]. In Uganda, women were three times
more likely to attend a six-week postnatal care appointment if they
had provided a phone contact. The study’s authors posited that
such women were more open to being contacted by health
personnel than women who did not provide a phone contact, and
also might be more likely to accept entry into the medical care
system and/or to have a good socioeconomic status that
empowered them to make informed decisions [44].
Religious Beliefs. Religion was found to influence adher-
ence and retention in three studies. In a quantitative study in
Uganda, being Christian was found to be a predictor (through
correlation) for ART adherence among women over 25 years of
age [44]. Another quantitative study in Zimbabwe found that
belonging to a religion that promoted the use of traditional herbs
during pregnancy (i.e., not biomedical care) reduced visits to
antenatal care (ANC) clinics and/or use of sdNVP [38]. Similarly,
a mixed-method study from Ghana found that the use of
alternative medicines and/or participation in overnight prayer
camps contributed to ART interruption and loss to follow-up [22].
Alcohol and Substance Abuse. Alcohol and/or illicit drug
use were barriers to ART adherence during and after pregnancy
in two U.S. studies [21,25], and a multi-country Latin American
study found tobacco use was negatively associated with adherence
[37]. No studies from sub-Saharan Africa included these factors in
their data.
Table 4. Cont.
Level of
Influence Key Review Finding Strength of Evidence Summary Generalizability/Transferability Summary
2b) Relationships within
the family affect
ART initiation, adherence,
and retention.
Moderate This finding was reported in three
qualitative papers and a mixed method study.
Designs were robust and the evidence was
descriptive in all four studies.
Low This finding was reported in a small number of
largely descriptive papers.
Community 3) Stigma within a
community can be a
significant barrier to
ART initiation, adherence,
and retention.
High This finding was reported in 15 papers,
almost all of which were based on qualitative
studies. Data on stigma as a barrier typically
came in the form of participant self-report.
One quantitative study described self-disclosure
as an enabler of access to HIV care and
adherence to ART.
High This finding was reported across a wide range
of contexts, especially studies in which women
identified barriers to initiating, adhering to, or
remaining on treatment.
Structural 4a) Higher participation
in recommended health
services leads to increased
likelihood of ART initiation,
adherence, and retention.
Moderate This was a core finding in six
quantitative papers. Delivery in a health
center was found to be an enabler in two studies,
although one was derived from a conference
abstract with limited detail. Two papers
reported an association between ART adherence
and receiving treatment (e.g., tuberculosis
treatment or multivitamins) for other conditions.
Moderate This finding was reported across a range
of contexts.
4b) Logistical problems
around access to services
can be barriers to ART
initiation, adherence, and
retention.
Moderate Seven papers with a range of
designs (i.e., four qualitative, two mixed
method, and one quantitative) reported this finding.
Transportation problems were described descriptively
in four well-designed studies, and cost was reported
as a limited finding in one quantitative study. Long
queues at health facilities were report as barriers to
initiation, adherence, and retention in four papers of
differing methods.
Moderate This finding was reported across a range
of contexts and designs. The finding is generalizable,
though specific factors may be context-dependent.
4c) Interactions with
health workers are
valued, and affect
the quality of access,
and likelihood of ART
initiation, adherence,
and retention.
High Seven studies reported that health
worker attitudes influenced whether women
initiated and adhered to ART. Qualitative studies
with strong designs reported that women’s
perspective of beneficial interactions encouraging
adherence. One quantitative paper proposed a
second order interpretation that adherence is
due to nurses taking opportunities to engage
more effectively with patients. Positive interactions
with doctors and traditional birth attendants
were noted as enablers of ART initiation,
adherence, and retention in two strong
qualitative papers.
Moderate This finding was reported qualitatively
across a range of contexts, suggesting strong context
validity, and reasonable generalizability.
doi:10.1371/journal.pone.0111421.t004
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Interpersonal Factors
Interpersonal barriers and enablers are those influenced by both
the woman and other individuals in her life, such as her partner or
family members. The review found that a woman’s relationships
within her immediate family could profoundly influence her ART
initiation, adherence and retention. The degree of the impact of
these factors often depended on the extent to which she had
disclosed her status and the extent to which family members who
knew her status supported her. Interpersonal findings specific to
women’s partners or spouses are discussed below, followed by
findings related to other family members.
Spouse or partner. Eighteen studies highlighted the role and
impact of a spouse/partner on ART initiation, adherence, and/or
retention. This was one of the most widely reported findings across
the reviewed studies. Studies in Rwanda, Uganda, and Malawi
found that women often felt a need for their partners’ permission
to initiate, adhere to, and be retained in ART care [26,27,45]. In a
rural Tanzanian study, women reported being dependent on their
partners for transportation to health facilities, so consistent
participation in an ART program was difficult if they had not
disclosed their status [35]. Similarly, in Uganda, non-disclosure of
HIV status to a partner was the second most commonly cited
barrier to enrolling in a PMTCT program [27].
Many of these women explained that economic dependence on
their husbands and/or fear of domestic violence inhibited them
from disclosing their status [27]. Domestic violence - actual or
anticipated - was also reported as a barrier to disclosure and ART
adherence in a South African study [41].
Other studies in France, Kenya, South Africa, and Tanzania
also found that non-disclosure of HIV infection to a spouse was a
barrier to ART initiation and retention [29,30,47,50]. Three of
these studies were qualitative and provided detailed insight into
women’s relationships with their husbands, and the influence of
those relationships on ART interventions. For example, in the
South African study, some women specifically asked to delay their
ART enrolment because they needed more time (e.g., a week or a
month) to disclose their HIV status to their partners [47]. Two
quantitative studies in Zimbabwe and South Africa found strong
associations between a woman disclosing her HIV status to a
partner and taking sdNVP, as recommended, at the start of labor
[38,46].
Several studies assessed the impact of a partner’s involvement in
a woman’s HIV care. Partner involvement was indicated by
factors such as knowledge that the woman had been referred to
HIV treatment, accompanying her to health appointments, or
participating in couples counselling. In Kenya and Zambia, studies
identified partner involvement as an enabler of ART initiation.
Similarly, in South Africa, partner involvement was identified as
an enabler of ART adherence [32,36,46]. Findings for this factor
in relation to retention were inconsistent in Malawi, however,
where one study found lack of male involvement as a barrier to
ART retention [23], and another found it as an enabler [34].
Family. Family members were cited as either important
facilitating or inhibiting influences by different studies. A family’s
embrace of community norms around stigma (discussed in more
detail below as a key community-level factor), and the consequent
pressure to maintain role and status within families can lead
women to keep HIV infection a secret, creating a barrier to ART
initiation and adherence. This relates to the barrier created when
decision making about the pregnant woman’s health/health care is
made by an elder female family member, as seen in a Kenyan
study [48]. Another study from Malawi found that grandmothers
strongly influenced pregnant women’s choice of delivery, provider
and location options (e.g., a traditional birth attendant at home)
[45]. This lack of autonomous maternal decision-making capacity
appeared to restrict HIV-infected women’s ability to adhere to
ART and PMTCT protocols. Only one study reported broader
family support as an enabler of adherence during pregnancy, by
helping women more with domestic tasks at home and allowing
them time to attend appointments [60].
Community Factors. This section addresses barriers and
enablers of pregnant and postpartum women’s ART initiation,
adherence and retention at the community level. These factors
relate to a woman’s broader social network and context. Stigma
and disclosure are the two critical community-level factors that
appeared most frequently in the studies described below.
Stigma. Like spousal disclosure and support at the interper-
sonal level, stigma was one of the most widely reported influences
on women’s ART initiation, adherence and retention at the
community level. In some cases, women’s direct experience of
stigma were barriers to successful ART outcomes, while in others,
fear of anticipated stigma was a barrier for women who had not
disclosed their HIV status publicly. Seven qualitative studies, two
mixed-methods studies, and two quantitative studies reported
stigma as a barrier.
Studies in Uganda, Malawi (two), South Africa, and Tanzania
found that HIV-related stigma was a barrier to women’s ART
initiation and retention, or their use of sdNVP. Some women in
these studies reported not initiating treatment because they feared
others would learn of their HIV infection and blame or stigmatize
them; some also feared their husbands would divorce them
[23,45,49,50,61].
Similarly, other studies in Malawi, South Africa (three), Nigeria,
Uganda, and Kenya reported that stigma inhibited ART
adherence and, in one case, retention. Many women who had
not disclosed their HIV status publicly feared there was insufficient
confidentiality within health facilities; this fear contributed to
women missing appointments and not participating in broader
HIV services, such as patient support groups
[24,28,41,43,44,48,52].
Disclosure. Studies in Zimbabwe and South Africa identified
positive experiences with disclosure as enablers of ART adherence
during pregnancy [38,46]. Specifically, women in the Zimbabwe
study reported that disclosure to someone other than their spouse
had been beneficial to their adherence [38]. The South African
study similarly found that disclosure not resulting in stigmatization
was positively associated with maternal ART adherence. A third
study from Kenya found that having ART clinics separate from
main hospital buildings reduced clinic attendance and ART
adherence; women were concerned their HIV infection would be
disclosed publicly by their attendance at the HIV-only sites [60].
Structural factors. Structural influences on a woman’s ART
initiation, adherence and retention are those within her broader
environment (beyond the local community/social context) that are
beyond her control and agency (e.g., organizational, economic,
legal, and policy factors). The main structural barriers and
enablers identified in this review relate to health system usage,
access, and engagement. The studied reviewed rarely made
mention of broader other barriers such as economic marginaliza-
tion, gender norms or the legal and policy context. Most reference
to these factors were made in relation to issues of health care
access and use.
Access to health services. Difficulty obtaining or paying for
transport to facilities was a barrier in studies from Uganda,
Tanzania, Malawi, and South Africa [27,35,45,47,50]. No studies
specifically highlighted the costs of services as a barrier to ART
initiation, adherence or retention. However, authors of a Kenyan
study speculated that the cost of HIV service registration may have
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contributed to some women not attending services or being lost to
follow-up [29], while authors of a Nigerian study posited that the
free nature of services was an enabler of adherence [28].
Additionally, several studies identified long queues and wait times
as barriers to ART initiation, adherence, and retention in Kenya,
Malawi, and Uganda, and Zimbabwe [24,27,42,60].
Use of health services. Several studies found that the more
women participated in recommended health services, the more
likely they were to initiate, adhere to and be retained in ART care.
For example, studies in Tanzania and Kenya found that low
antenatal care (ANC) attendance (i.e., less than three visits) was
associated with lower rates of ART initiation and retention
[29,50]. Interestingly, women who were pregnant for the first time
were more likely to register at an HIV clinic than women who had
been pregnant before–the authors speculated this might be
because women tended to be more anxious about their own and
the fetus’ health during their first pregnancy [29]. In a Kenyan
study, women who disengaged from HIV services in the 30 days
before delivery (i.e. late disengagement) were more likely to be lost
to follow up postpartum when compared to women who stayed
until delivery [20].
Delivery at a health facility was associated with ART initiation
in studies in Kenya and Rwanda [26,36]. The Rwandan study
found that women delivering in health centers were more likely to
have had two or more ANC visits, and to have received sdNVP at
the onset of labor [26]. Although this study focused on sdNVP use,
it was included in this review because it is indicative of the
enabling effect of prior interaction with the health system. In the
Kenyan study, women receiving treatment for other conditions
(e.g., tuberculosis) were less likely to disengage from ART services,
and those receiving PMTCT were more likely to register at an
HIV clinic and to be retained in long-term HIV care [20].
Health worker attitudes. Eight studies reported that health
workers’ attitudes influenced women’s initiation and adherence to
ART. Studies in Brazil, Kenya, Malawi and South Africa found
that negative health worker attitudes were barriers to ART
initiation [29,31,33,49]. Studies from Australia, Malawi, Uganda,
and South Africa found that negative attitudes were a barrier to
both adherence and retention during and/or after pregnancy
[27,39,45,47,49]. In these studies, negative provider attitudes were
exemplified by health workers in Uganda who reportedly were
uninterested or too busy to interact with women or provide them
with medication [27], and by health workers in Malawi who
reportedly shouted at women attending HIV services [45]. Studies
in Kenya and Malawi found that women’s concern that health
workers would not maintain confidentiality also inhibited adher-
ence or retention [24,60].
Positive, non-judgmental attitudes from health workers –
described in a Brazilian study as ‘‘warmth’’ – were found to be
an enabler for ART adherence [31]. A Malawian study found that
traditional birth attendants (TBAs) were preferred over health
workers because they were more accessible and positive towards
women, underscoring the importance of ensuring respectful care
in antenatal, maternity, postnatal and HIV services [45].
Discussion
Overview of Findings and Programmatic Implications
This review identified a range of individual, interpersonal,
community, and structural factors that inhibit or facilitate HIV-
infected pregnant and postpartum women’s ART initiation and
adherence. Only four of the 34 included studies described or
evaluated an intervention. Thus, we are not able to make
evidence-based recommendations for specific interventions to
improve HIV-infected women’s access to and use of prenatal and
postpartum ART. However, the review’s descriptive findings
suggest broad areas of intervention needs for this population, and
these are discussed below in the context of the general literature on
ART adherence barriers, facilitators, and interventions.
Individual level factors. This review found that many
studies reported barriers to ART initiation, adherence, and
retention that were related to poor understanding of HIV, ART,
and PMTCT. For example, some women believed they did not
need to initiate ART because they felt too healthy or feared ART
would harm the fetus. Other studies identified poor knowledge
about how PMTCT worked as both a barrier to ART initiation
and adherence as well as retention in care postpartum. These
findings may be especially important going forward with the
growing roll-out of Option B+, as increasing numbers of healthy-
feeling women are initiated on ART [62].
This review did not set out to assess women’s knowledge of
HIV, ART and PMTCT and can therefore make no general
findings about these levels of knowledge. The review can provide
indirect evidence, however, that gaps in knowledge about HIV,
ART and PMTCT continue to act as barriers to critical health
services and highlight the need for improving the provision of
information within and outside of health services. While it is
disappointing that poor understanding of HIV still persists, this
finding indicates a promising way forward, in that improving
knowledge is generally considered one of the simplest and most
straight-forward behavior change interventions [63].
Other common individual-level problems were forgetting to
take ART, misplacing it, or not having access to it when traveling.
Our findings indicate the women would benefit from support in
developing routines and approaches for self-monitoring and
remembering to take their medication. Such interventions should
use locally available and culturally appropriate systems, such as
intensive counseling within health facilities or strengthening
community-based support systems (e.g., maximizing the discreet
and convenient potential of mobile-phone text reminders or
supporting home-based care providers who remind women to take
and renew their medications and accompany them to appoint-
ments, as needed) [64–67]. The discipline, commitment, and
coordination required for ART adherence over an extended
period should not be underestimated.
Interpersonal level factors. Many studies reported on the
crucial influence of husbands or partners, both positive and
negative. Disclosure of HIV infection to a spouse and spousal
involvement in a woman’s treatment were both associated with
improved initiation, adherence, and retention. However, multiple
studies also reported that women were reluctant to disclose their
HIV status to partners because they feared significant negative
consequences. Importantly, it is not possible to know the direction
of cause and effect in these findings. It is possible that women who
choose to disclose to their partners already have positive and
supportive relationships, in comparison to women who do not
disclose, and that these positive relationships in themselves
promote ART initiation, adherence, and retention. Alternatively,
for some women, the process of disclosure itself (regardless of
relationship quality) may be a critical factor in promoting ART
initiation and/or adherence.
In either case, these findings highlight the importance of ART
programs that focus on the continuum of care for women,
acknowledge the role these relationships may have in ART
initiation, adherence, and retention, and incorporate interventions
that take into account the relevance of women’s primary
relationships. Maternal ART program staff can provide counseling
for women who have not yet disclosed their status to their partners,
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communication skills exercises, couple counseling to help them to
disclose, or practical strategies for ART adherence if they are
unwilling or unable to disclose to their partners. Very few of the
interventions identified in this review addressed the role of power
and interpersonal relationships, reflecting a broader tendency
among individual-level HIV interventions to focus on knowledge
and planning skills [68].
Community level factors. At the community level, this
review found the experience of stigma, or the fear of stigma, to be
a substantial barrier to ART initiation, adherence and retention
among pregnant and postpartum women. Other reviews have also
found stigma to have a significant influence on ART initiation and
adherence [69]. Basic misunderstandings about HIV and AIDS
persist in much of the world; for example, UNAIDS’ 2010 Global
Report on the AIDS Epidemic found that, in 15 of the 25 countries
with the highest HIV prevalence rates, less than half of young
people could answer five basic questions about HIV correctly [70].
Misunderstandings about the effectiveness and value of ART and
PMTCT may contribute to community-level stigmatization of
women who are discovered to be HIV-infected because they
participate in ART programs. These findings highlight the need
for intensive interventions focused on raising knowledge and
awareness about the effectiveness and value of ART and PMTCT,
and the harmful effects of stigma [71,72].
Structural level factors. This review’s findings underscore
the importance of HIV services providing intensive, targeted
support tailored to the unique needs and circumstances of HIV-
infected women during pregnancy. For effective ART initiation,
adherence, and retention, women may need in-depth orientation
and counseling sessions to ensure they fully comprehend the
importance of ART, to help them through the process of disclosing
their status to husbands/partners/families, and to strategize about
how they can reliably take their medication [73,74].
HIV services ideally should be integrated with other maternal
and child health services to maximize efficiency for the client,
service delivery, and confidentiality (e.g., one-stop ANC and ART
appointments). Integrated services would also support confidenti-
ality and reduce fear of stigma among women who have not yet
disclosed their status. Regardless of the specific program design of
the maternal, child, and HIV health services in a particular
context, however, this review also highlighted the critical role that
health worker attitudes played in encouraging–or more often
discouraging–access to and use of HIV services.
Are the pregnancy and postpartum periods unique?
Many of our findings related to ART initiation, adherence, and
retention for HIV-infected pregnant and postpartum women are
similar to those reported for people living with HIV (PLHIV) more
broadly, including enablers such as social support [64,65] and
barriers such as fear of disclosure and stigma, lack of knowledge
about HIV and ART, or difficulty obtaining transportation to
facilities [74,75]. In fact, the most urgent findings from this
review–the continuing influence of stigma at both interpersonal
and community levels, the surprising persistence in knowledge
gaps, and the ongoing missteps and missed opportunities in the
HIV-related health services–reflect long-standing challenges in
ART programming for adults more generally.
A question arising from this recognition, however, is how
individual and contextual barriers and enablers for pregnant and
postpartum women might differ in important ways from those of
the general population of PLHIV. While we did not directly
compare findings between pregnant and non-pregnant women
with HIV, the review suggests that some enablers may have a
stronger influence on pregnant and postpartum women. For
example, pregnant women are more likely than others to visit
health facilities regularly, which, under ideal circumstances, would
promote ART initiation, adherence, and retention and relatively
prompt care for other conditions. A recent assessment of the
beneficial effect of pregnancy on presentation for HIV care found
that non-pregnant women were twice as likely to present late when
compared to pregnant women [76]. The studies in this review also
identified ways in which pregnant women may receive special
support from partners and other family members who assist them
in domestic and other work activities. Concern for the health of
the fetus may also facilitate or inhibit adherence to ART.
Some barriers to ART initiation, adherence, and retention may
also be intensified for pregnant or postpartum women. Women in
multiple studies reviewed reported increased demands or respon-
sibilities due to their pregnancy, caring for an infant, and/or
physical conditions post-delivery as barriers to adherence or
retention in care [19,42,45,47]. Many women maintain their usual
responsibilities with little assistance while pregnant. Pregnancy can
be physically demanding and tiring, and there may be additional
commitments to maintain, including regular health care appoint-
ments at distant facilities. This highlights a particular concern for
pregnant women who only learn of their HIV infection when
screened during pregnancy, and are then initiated on ART. These
women must quickly adjust to being pregnant, being HIV-
infected, and to a daily treatment regimen they will need to follow
for the rest of their lives. Each of these changes may tax a woman
emotionally and physically, and may be further exacerbated
during the postpartum period, when she is both recovering from
the delivery as well as breastfeeding and caring for an infant day
and night. All of these conditions help suggest why barriers to
ART initiation, adherence, and retention, common to many
PLHIV, may become more pronounced for some women during
pregnancy and postpartum.
Review limitations
The strengths of this review’s design included its inclusive search
strategy that ensured wide coverage, dual inclusion and data
extraction, and iterative analysis. Limitations in the review design
included its rapid pace, which prevented more exhaustive searches
of the gray literature and inclusion of studies in languages other
than English.
Given the diversity of the evidence base with respect to settings,
ART/PMTCT program types and protocols, and study questions
and designs, we have not been able to transform or interpret the
data beyond the descriptive, thematic analysis presented above.
The diversity of evidence included here is a strength in terms of
the richness it provides, but generalizability and transferability
across contexts was limited by a range of factors. First, there was
great variance in how adherence was defined and measured across
the reviewed studies, limiting our ability to synthesize findings
across studies (see Supporting Information for a table summarizing
the outcome measures used in the included studies). Second,
studies differed greatly in the range of ART regimens they
evaluated, which also limited our ability to integrate and interpret
findings, particularly since some ART barriers and enablers may
be particular to specific regimens.
Third, many studies did not clearly distinguish between
individual and contextual factors influencing ART initiation,
adherence, and retention during pregnancy from those influencing
postpartum ART adherence, a time when conditions for women
are likely to be very different. Finally, many identified barriers and
enablers may be regionally or culturally specific. While this may in
general limit the transferability of the findings outside of sub-
Saharan Africa–and in particular high-prevalence regions within
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Southern Africa–it does potentially increase their transferability
with this region, and possibly to regions with similar levels of HIV
prevalence and health system challenges. A further threat to
transferability of the contextually specific findings, however, is the
fact that few of the articles provided rich enough detail to know
when particular findings might be transferable to similar contexts.
Research agenda
This review has revealed several gaps in the existing evidence
base, gaps that collectively point to what we argue should be key
parts of the research agenda going forward. Perhaps the most
important gap, and a critical focus of future research, is the women
who do not appear in these studies–those who did not make it to
antenatal care or HIV testing, or who dropped out along the
maternal ART cascade. Much of the research we reviewed is
focused on health systems issues and women’s engagement with
these systems. Consequently, we know a great deal more about
who stayed in care and why than about those who never attended
entered the system or who dropped out early [77]. None of the
included studies examined the barriers that women who do not
enter into care experience in accessing maternity services and
initiating ART during pregnancy or postpartum. We need a great
deal more research–and programming–aimed at understanding
and supporting such women. Loss-to-follow-up is particularly
likely to happen postpartum [40], which suggests this is an area
that also needs increased attention as Option B+ is scaled up.
There is also limited examination of health beliefs in the
literature. Alternative treatment-seeking, particularly for tradition-
al medicine, is widely practiced in many countries with high HIV
prevalence [78], but these choices were minimally addressed
within the reviewed studies. This likely reflects the number of
studies that took place within the health system, and highlights the
need for community-based research focused on how alternative
health-seeking behaviors may intersect with ART initiation,
adherence, and retention among pregnant and postpartum
women. Similarly, our understanding of how interpersonal and
community-level factors operate would benefit from more research
examining the impact of HIV and treatment on women’s
aspirations and expectations, their roles and status within families,
and the broader social dynamics in relation to pregnancy and
HIV.
Finally, this review highlighted a critical methodological gap
and area for future improvement–the need for meaningful,
standardized ART adherence and retention performance indica-
tors within programs and research. Measuring ART adherence
and retention is critical for PLHIV care and treatment and
broader efforts to minimize ART resistance, but collecting valid
data on these outcomes is not straightforward. Adherence
measures based on dispensing and appointment-keeping data are
increasingly being implemented within health systems [79], but
measures which assess adherence behaviors more broadly among
PLHIV vary widely. There are also important questions to answer,
however, with respect to how valid adherence measures for
pregnant and postpartum women may differ from standard
appointment-based measures in the short-term, given pregnant
women’s unique schedule of contact with the health system during
pregnancy and postpartum. Finally, very few of the studies
measured adherence or retention measures in the long-term and
provided little guidance on how and why women may cycle
through periods of better and worse adherence or even drop in
and out of care episodically. Our understanding of pregnant and
postpartum women’s access to and use of ART would benefit
greatly from research that used consistent, standardized, and
appropriate measures of adherence and retention that had a
longitudinal component.
Conclusion
The potential of antiretroviral therapy to prevent avoidable
maternal deaths among HIV-infected women is great. The success
of this strategy, however, will depend on careful consideration of
the barriers and enablers to pregnant and postpartum women’s
access to and use of ART. Managing these barriers and enhancing
known enablers will require the development of respectful and
locally acceptable HIV and ANC service delivery models that are
responsive to women’s needs and perspectives, and support them
as they enter and move through the maternal ART cascade. It will
also require better understanding the ways women’s lives outside
of the clinic affect their chances of entering into, and staying
adherent to and retained in care.
This review of individual and contextual factors, along with the
two companion reviews which assess the evidence on the
effectiveness of interventions to decrease death and morbidity
among HIV-infected pregnant and postpartum women [12] and
examine the health system barriers and enablers to ART initiation,
adherence, and retention among this group [13], point to
strategies that may be effective in expanding the reach of ART.
Translating this evidence into practice is critical for keeping
pregnant women and mothers alive and preventing new HIV
infections among their children as we endeavor to achieve the
global goals of an AIDS-Free generation and ending preventable
child and maternal deaths.
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